BG
EMN icon

Bahl & Gaynor’s Eastman Chemical EMN Stock Holding History

Bahl & Gaynor’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-11,080
Closed -$907K – 439
2015
Q2 		$907K Buy
11,080
+100
+0.9% +$7.71K 0.01% 241
2015
Q1 		$760K Buy
10,980
+1,306
+14% +$94.3K 0.01% 249
2014
Q4 		$734K Sell
9,674
-436
-4% -$34.5K 0.01% 247
2014
Q3 		$818K Buy
10,110
+41
+0.4% +$3.42K 0.01% 235
2014
Q2 		$880K Hold
10,069
– – 0.01% 222
2014
Q1 		$868K Buy
10,069
+625
+7% +$51.2K 0.01% 214
2013
Q4 		$762K Buy
9,444
+550
+6% +$42.7K 0.01% 220
2013
Q3 		$693K Buy
8,894
+2,520
+40% +$194K 0.01% 218
2013
Q2 		$446K Buy
+6,374
New +$444K 0.01% 245

Other funds holding EMN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Bahl & Gaynor's EMN Position: Q3 2015 in Review

Bahl & Gaynor sold out of Eastman Chemical (EMN) in Q3 2015, closing a stake of 11,080 shares — an estimated $907K sold.

Bahl & Gaynor first reported a position in EMN in Q2 2013 and held it in 9 quarters. The position peaked at $907K in Q2 2015. 567 funds tracked by Wall St. Rank hold EMN as of Q3 2015.

  • Bahl & Gaynor reported no remaining Eastman Chemical position as of Q3 2015 after selling out during the quarter.
  • Bahl & Gaynor sold 11,080 Eastman Chemical shares in Q3 2015, an estimated $907K.
  • Bahl & Gaynor first reported a position in Eastman Chemical in Q2 2013 and held it in 9 quarters.
  • Bahl & Gaynor's Eastman Chemical position peaked at $907K in Q2 2015.
  • 567 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2015.

Based on Bahl & Gaynor's 13F filing for Q3 2015, filed 10 Nov 2015.